Controlled Clinical Trial
Journal Article
Add like
Add dislike
Add to saved papers

CD34+ progenitor cells in pulmonary sarcoidosis.

UNLABELLED: Sarcoidosis is a disease of unclear etiology, immunopathogenesis complex and diverse clinical course.

AIM: The aim of study was to evaluate the usefulness of CD34+ cells, CD4 and CD8 lymphocytes in peripheral blood for the diagnosis and better understanding of the sarcoidosis pathogenesis.

MATERIALS AND METHODS: The study included 40 patients (16 women and 24 men) aged 29-71 years (mean 45 years) with newly diagnosed pulmonary sarcoidosis. The control group consisted of 30 healthy subjects (18 women and 12 men) aged 24-65 years (mean 47 years). Tests were performed in peripheral blood, and lymphocytes CD4 and CD8 and progenitor CD34+ cells surface antigens were determined by flow cytometry.

RESULTS: It has been shown that number of CD34+ progenitor cells in peripheral blood was significantly higher in patients with newly diagnosed pulmonary sarcoidosis and showed a positive correlation with CD4/ CD8 rate.

CONCLUSIONS: CD34+ progenitor cells may be important in the pathogenesis of sarcoidosis. It is necessary to conduct further studies that identify heterogenous population of CD34+ cells with particular focus on fibrocytes.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app